 |
5′-O-(trans-9″-octadecenoyl)-1-beta-D-2’deoxy-2′,2′-difluorocytidine |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2009-12-07 00:00:00 |
| Sponsor | Clovis Oncology, Inc.;5500 Flatiron Parkway, Suite 100;Boulder, Colorado, 80301 |
